Parker Waichman LLP

Federal Regulators Seek Permanent Injunction Against Pharmaceutical Innovations, Inc.

On October 3, 2014, the U.S. Food and Drug Administration announced that it is seeking a permanent injunction to stop Pharmaceutical Innovations Inc., and its principal officer, Gilbert Buchalter, from manufacturing, marketing, selling, and distributing any medical products until those products come into compliance with all applicable FDA requirements. Pharmaceutical Innovations Inc. is a Newark, […]

On October 3, 2014, the U.S. Food and Drug Administration announced that it is seeking a permanent injunction to stop Pharmaceutical Innovations Inc., and its principal officer, Gilbert Buchalter, from manufacturing, marketing, selling, and distributing any medical products until those products come into compliance with all applicable FDA requirements.

Pharmaceutical Innovations Inc. is a Newark, New Jersey-based medical device firm that manufactures ultrasound, mammography, and electrocardiogram gels, and scanning pads. The devices are used for diagnostic purposes in the health care environments.

The complaint for permanent injunction was filed by the U.S. Department of Justice on behalf of the FDA on October 2, 2014, in the U.S. District Court for the District of New Jersey.

Complaint allegations include that Pharmaceutical Innovations Inc. did not conform with current good manufacturing practice requirements, as mandated under the Federal Food, Drug, and Cosmetic Act, when they manufactured their devices. The complaint also alleges that the firm distributed its products nationwide without required pre-market approval or clearance.

Also included in the complaint are details concerning the United States marshals, who were acting on a request by the FDA. The marshals seized specific lots of Other-Sonic Generic Ultrasound Transmission Gel in April 2012. The seizure occurred after the agency’s laboratories discovered a significant amount of Pseudomonas aeruginosa and Klebsiella oxytoca in these lots.

These bacteria present significant infection risks, including pneumonia, to exposed individuals. In fact, the agency is aware of people infected with Pseudomonas aeruginosa following surgical procedures that took place at one Michigan hospital and that involved Pharmaceutical Innovations Inc.’s “Other-Sonic Generic Ultrasound Transmission Gel.”

The agency issued a safety alert to the health care community on April 18, 2012, advising use of the contaminated product be ceased. Melinda K. Plaisier, the FDA’s associate commissioner for regulatory affairs noted that, “Despite multiple warnings by the FDA over the past three years, and promises to correct the numerous ongoing violations, the defendants continued to violate the law.” She added that, “This presents serious health risks to patients who used and continue to use the company’s products.”

A prior recall on the “Other-Sonic Generic Ultrasound Transmission Gel” was deemed a Class I in 2012 by the FDA. A Class I recall designation involves a situation in which there exists a reasonable probability that the use of, or exposure to, a violative product will cause serious adverse health consequences or death.

“Other-Sonic Generic Ultrasound Transmission Gel” is a non-sterile gel utilized in ultrasound procedures for the purpose of improving the transmission and receipt of ultrasound waves. Although this product is not labeled as either sterile or non-sterile, it is NOT sterile.

What Our Clients Say About Us
We have worked with thousands of clients and we appreciate them and their positive reviews. Here are just a few recent client reviews...
5 Star Reviews 150
Thanks to Waichman LLP for winning my case and Joarge Peniche for his work
Adrian Rubi
a year ago
5 Star Reviews 150
I had the pleasure of meeting Ms. Josama, Parker Waichman’s Settlement Coordinator. Ms. Josama was was extremely competent and professional.
Asher Kennedy
4 years ago
5 Star Reviews 150
Positive: Professionalism Benita Rollis was very professional and kind while helping us through the entire process of our case. I would definitely recommend Parker Waichman and Ms. Rollis.
Jennifer Young
2 years ago

Why Choose Us to Help You?

We Take Care of Everything
Your situation is stressful enough: Let us take on the deadlines, paperwork, investigation, and litigation. We'll handle every detail so you don't have to worry.
No Recovery = No Legal Fees
We work on a contingency-fee basis, meaning that we only get paid from a portion of your settlement or jury award. If you don't get compensation, you owe us nothing.
Decades of Experience
Your situation is stressful enough: Let us take on the deadlines, paperwork, investigation, and litigation. We'll handle every detail so you don't have to worry.
Respected by Our Peers
Judges, insurance adjusters, and fellow attorneys all speak highly of our skills, and we've earned numerous accolades, including a flawless rating from AVVO.
We Have Many Locations To Serve You
We have the experience and the skilled litigators to win your case. Contact us and speak with a real attorney who can help you.
Long Island – Nassau
Parker Waichman LLP
6 Harbor Park Drive
Port Washington, NY 11050
Long Island – Suffolk
Parker Waichman LLP
201 Old Country Road – Suite 145
Melville, NY 11747
New York
Parker Waichman LLP
59 Maiden Lane, 6th Floor
New York, NY 10038
Queens
Parker Waichman LLP
118-35 Queens Boulevard, Suite 400
Forest Hills, NY 11375
Brooklyn
Parker Waichman LLP
300 Cadman Plaza West
One Pierrepont Plaza, 12th Floor
Brooklyn, NY 11201
New Jersey
Parker Waichman LLP
80 Main Street, Suite 265
West Orange, NJ 07052
Florida
Parker Waichman LLP
27299 Riverview Center Boulevard
Suite 108
Bonita Springs, FL 34134
Nationwide Service
Parker Waichman LLP
59 Maiden Lane, 6th Floor
New York, NY 10038